Key result
A pharmacist-led telephonic Medication Therapy Management program identified medication-related problems in 33 rural patients, though implementation was limited by poor patient follow-up.
Why the study?
This study was conducted to evaluate a pharmacist-led telephonic Medication Therapy Management program for patients in rural Arizona with diabetes and/or hypertension and poor access to healthcare services.
Does a pharmacist-led telephonic Medication Therapy Management program identify medication-related problems in rural adult patients with diabetes and/or hypertension?
Observational (n=33)
Does a pharmacist-led telephonic Medication Therapy Management program identify medication-related problems in rural adult patients with diabetes and/or hypertension?
While pharmacist-led telephonic MTM can identify medication issues in rural populations, systemic barriers such as poor follow-up and low implementation rates limit its overall clinical impact.
Answers are grounded in this paper and cite their sources.
Implementation barriers limit pharmacist MTM value in rural diabetes/hypertension despite identification; leaves open whether addressing follow-up improves outcomes.
This study evaluated a pharmacist-led telephonic Medication Therapy Management (MTM) program for rural patients in Arizona with poor access to healthcare services. A pharmacist provided telephonic MTM services to eligible adult patients living in rural Arizona communities with a diagnosis of diabetes and/or hypertension. Data were collected and summarized descriptively for demographic and health conditions, clinical values, and medication-related problems (MRPs) at the initial consultation, and follow-up data collected at 1 and 3 months. A total of 33 patients had baseline and one-month follow-up data, while 15 patients also had three-month follow-up data. At the initial consultation, the following MRPs were identified: medication adherence issues, dose-related concerns, adverse drug events (ADE), high-risk medications, and therapeutic duplications. Recommendations were made for patients to have the influenza, herpes zoster, and pneumonia vaccines; and to initiate a statin, angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, and/or rescue inhaler. In conclusion, this study demonstrated that while pharmacists can identify and make clinical recommendations to patients, the value of these interventions is not fully realized due to recommendations not being implemented and difficulties with patient follow-up, which may have been due to the COVID-19 pandemic. Additional efforts to address these shortcomings are therefore required.
No takes yet. Share an insight, caveat, or question.
Axon et al. (2022) conducted an observational in Diabetes and/or hypertension (n=33). Pharmacist-led telephonic Medication Therapy Management (MTM) program was evaluated on Medication-related problems (MRPs) and clinical recommendations. A pharmacist-led telephonic Medication Therapy Management program identified medication-related problems in 33 rural patients, though implementation was limited by poor patient follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: